We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Clinigen Group Plc | CLIN | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 925.00 | 00:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 925.00 | 925.00 |
| Top Posts |
|---|
Posted at 17/1/2022 08:32 by ali47fish amazed that nobody is commenting on bidco raising the offer for clin |
Posted at 09/12/2021 09:12 by tomps2 Andy Brough interview with PIWORLDAndy Brough mentions Clinigen #CLIN in the latest PIWORLD interview at 17m18s then again at 19m Watch the video here: Or listen to the Podcast here: |
Posted at 08/12/2021 08:20 by r2oo My thoughts exactly, the dividend is locked in so why wait for the sale to go through at a lower price?Anyone have any insight into why this would still be going up well past the bid price? |
Posted at 02/12/2021 15:31 by hjs Fair value is around £9.8 to £10. I expect a good premium to be paid for CLIN. |
Posted at 23/11/2021 15:08 by essentialinvestor Elliott at 7.6% |
Posted at 24/9/2021 07:13 by tomps2 Christopher Mills mentions Clinigen (CLIN) at 16:58 in the latest Interview with PIWORLDWatch the video here: Or listen to the podcast here: |
Posted at 16/9/2021 15:24 by marvelman What a shower, Paying out a dividend with those results and yet trying to alleviate their debt at the same time. Would not surprise me to see a placing with this share price action. |
Posted at 13/7/2021 06:53 by whatja Well a positively glowing outlook for 21/22 and 22/23.Is that a come and get me call out to PE? If delivered the share price should look better in 6 and 12m time. Looking to pay off around 130m of debt in next two years. Proleukin looking sickly….may not recover but also washing its face against the debt taken on to buy it and he amortisation of its cost…. Clin will survive a big write down in Proleukin if it is needed, but management should avoid future big deals on waning drugs. |
Posted at 02/7/2021 13:49 by ali47fish tomps what's the gist of his message about clin? |
Posted at 10/6/2021 12:07 by sphere25 Nibbled a few on that break of 580p. The first spike back up above 570p (where the seller in size was sat) to test that key mark of 580p clearly wasn't the proper move as it was too sharp and fast and didn't give time for all the sellers to participate.It dropped back on participation, and the price then come back up to re-test that mark in a more measured (for CLIN) way, but with a material difference in what looks like sellers capitulating at 570p. Now we now have a breach of the intraday resistance with the price TRYING to rally back, currently at 589p. So a possible bounce here now (needs to clear 590p now for another bullish move), but if I'm wrong (not everything works and CLIN clearly isn't the easiest to trade), I'll stick a stop under that resistance of 580p and take a small loss. All imo DYOR |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
